A 24-Week Randomized, Double-Blind, Placebo-Controlled Study Of The Efficacy And Safety Of Once-Daily Umeclidinium/vilanterol 125/25 Mcg In COPD
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2013）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要